Chinese Ministry of Commerce approves Nestle's US$11.85B bid to buy Pfizer's infant nutrition business; Nestle still needs approvals from anti-trust bodies in several other countries

Nevin Barich

Nevin Barich

Nov 2, 2012 – Industry Intelligence Inc.

LOS ANGELES , November 2, 2012 () – The Chinese Ministry of Commerce has approved Nestle SA's US$11.85 billion bid to buy Pfizer's infant nutrition business, Dow Jones Newswires reported Nov. 2.

Nestle still needs approvals from anti-trust bodies in several other countries.

The primary source of this article is Dow Jones Newswires, New York, New York, on Nov. 2, 2012.

* All content is copyrighted by Industry Intelligence, or the original respective author or source. You may not recirculate, redistrubte or publish the analysis and presentation included in the service without Industry Intelligence's prior written consent. Please review our terms of use.


About Us

We deliver market news & information relevant to your business.

We monitor all your market drivers.

We aggregate, curate, filter and map your specific needs.

We deliver the right information to the right person at the right time.

Our Contacts

1990 S Bundy Dr. Suite #380,
Los Angeles, CA 90025 795

+1 (310) 558 0008
+1 (310) 558 0080 (FAX)

About Cookies On This Site

We collect data, including through use of cookies and similar technology ("cookies") that enchance the online experience. By clicking "I agree", you agree to our cookies, agree to bound by our Terms of Use, and acknowledge our Privacy Policy. For more information on our data practices and how to exercise your privacy rights, please see our Privacy Policy.